Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.8 NOK | -2.13% | +0.55% | -11.33% |
Sales 2024 * | 171M 15.47M | Sales 2025 * | 203M 18.4M | Capitalization | 568M 51.48M |
---|---|---|---|---|---|
Net income 2024 * | -11M -998K | Net income 2025 * | -6M -544K | EV / Sales 2024 * | 3.13 x |
Net cash position 2024 * | 34M 3.08M | Net cash position 2025 * | 15M 1.36M | EV / Sales 2025 * | 2.72 x |
P/E ratio 2024 * |
-49.2
x | P/E ratio 2025 * |
-86.4
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.85% |
Latest transcript on Gentian Diagnostics
1 day | -2.13% | ||
1 week | +0.55% | ||
Current month | -5.15% | ||
1 month | -6.60% | ||
3 months | -13.21% | ||
6 months | -8.00% | ||
Current year | -11.33% |
Managers | Title | Age | Since |
---|---|---|---|
Hilja Ibert
CEO | Chief Executive Officer | - | 18-07-15 |
Njaal Kind
DFI | Director of Finance/CFO | 52 | 18-01-01 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Settevik
CHM | Chairman | 64 | - |
Fredrik Thoresen
BRD | Director/Board Member | 44 | - |
Director/Board Member | 60 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 36.8 | -2.13% | 15,068 |
24-04-25 | 37.6 | 0.00% | 0 |
24-04-24 | 37.6 | 0.00% | 2,850 |
24-04-23 | 37.6 | +2.73% | 125 |
24-04-22 | 36.6 | 0.00% | 187 |
Real-time Oslo Bors, April 26, 2024 at 10:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.33% | 51.39M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- GENT Stock